MediWound (MDWD) Net Income Growth (3y) (2016 - 2025)

MediWound (MDWD) Net Income Growth (3y) (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 9.16%
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 38.43%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 13.80%
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -3.84%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 79.26%
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 MediWound 165.19 Mn 160.39 Mn 278,000.00 -1.19%

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.19%
Sep 30, 2025 14.20%
Jun 30, 2025 45.16%
Mar 31, 2025 41.30%
Dec 31, 2024 2.06%
Sep 30, 2024 -45.40%
Jun 30, 2024 58.39%
Mar 31, 2024 -39.43%
Dec 31, 2023 -0.21%
Sep 30, 2023 -4.82%
Jun 30, 2023 -33.37%
Mar 31, 2023 -14.49%
Dec 31, 2022 -29.38%
Sep 30, 2022 -172.29%
Jun 30, 2022 -30.04%
Mar 31, 2022 4.42%
Dec 31, 2021 -33.74%
Sep 30, 2021 -4.35%
Jun 30, 2021 -40.39%
Mar 31, 2021 7.61%